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Abstract
Background: In case of untreatable suffering at the end of life, palliative sedation may be chosen to assure comfort
by reducing the patient’s level of consciousness. An important question here is whether such sedated patients are
completely free of pain. Because these patients cannot communicate anymore, caregivers have to rely on
observation to assess the patient’s comfort. Recently however, more sophisticated techniques from the
neurosciences have shown that sometimes consciousness and pain are undetectable with these traditional
behavioral methods. The aim of this study is to better understand how unconscious palliative sedated patients
experience the last days of their life and to find out if they are really free of pain.
Methods: In this study we will observe 40 patients starting with initiation of palliative sedation until death.
Assessment of comfort based on behavioral observations will be related with the results from a NeuroSense
monitor, an EEG-based monitor used for evaluation of the adequacy of anesthesia and sedation in the operating
room and an ECG-based Analgesia Nociception Index (ANI) monitor, which informs about comfort or discomfort
condition, based on the parasympathetic tone. An innovative and challenging aspect of this study is its qualitative
approach; “objective” and “subjective” data will be linked to achieve a holistic understanding of the study topic. The
following data will be collected: assessment of pain/comfort by the patients themselves (if possible) by scoring a
Visual Analogue Scale (VAS); brain function monitoring; monitoring of parasympathetic tone; caregivers’ assessment
(pain, awareness, communication); relatives’ perception of the quality of the dying process; assessment by 2 trained
investigators using observational scales; video and audio registration.
Discussion: Measuring pain and awareness in non-communicative dying patients is both technically and ethically
challenging. ANI and EEG have shown to be promising technologies to detect pain that otherwise cannot be
detected with the “traditional” methods. Although these technologies have the potential to provide objective
quantifiable indicators for distress and awareness in non-communicative patients, strikingly they have not yet been
used to check whether the current assessments for non-communicative patients are reliable.
Trial registration: The study is registered on ClinicalTrials.gov (Identifier: NCT03273244; registration date: 7.9.2017).
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Background
Once death is imminent, a major concern of family
members and caregivers is to assure maximal comfort
for the patient during this terminal phase. This can often
be achieved by ‘conventional’ pharmacological drugs
such as opiates or other symptom-controlling drugs.
However, when symptoms are refractory or very severe,
e.g. suffocation, a more drastic option may be chosen,
known as palliative sedation, terminal sedation or con-
tinuous deep sedation (CDS). In such cases comfort is
sought by reducing the patient’s level of consciousness
[1]. Notwithstanding palliative sedation is ethically con-
troversial, this practice has substantially increased in
hospitals, nursing homes and in the home setting. The
overall reported incidences vary between 8% and 17% of
all deaths [2–5]. Although CDS is more often used in
palliative care settings, it is also applied in other popula-
tions such as coma patients and the demented elderly.
It is assumed that patients who are sedated according
to current standards of care and the guidelines of CDS
are unaware of their clinical situation and therefore do
not experience symptoms of discomfort such as dyspnea,
delirium, and other distressing conditions that are com-
mon during the terminal phase. However, a critical
evaluation based on more recent evidence raises the
question whether the current assessments of suffering
and awareness are accurate. Three kinds of problems
(assessment of (dis)comfort, the notion of (un)aware-
ness, and titration of drugs) can be discerned.
Problems with assessment of (dis)comfort in dying
patients
The gold standard for detecting distress is patient self-
reporting and several instruments, such as the Visual
Analog Scale (VAS) or the Numeric Rating Scale (NRS)
for pain, are based on this [6]. However, in the case of
CDS, patients are unable to communicate whether or
not they are still in distress or still (partially) aware of
what is going on with them. Some scales have been de-
veloped for non-communicative patients as well, but
several problems with those have been reported. One
well-documented problem is that such scales seem un-
able to detect pain and awareness in all patients, e.g. be-
cause they depend on inferences made from patients’
motor responsiveness, which in case of CDS are nonex-
istent [7]. Another problem is that these scales are only
partially, and in most cases not at all, validated for dying
patients [8–10]. In the guidelines for palliative sedation
it is acknowledged that the efficacy and safety of pallia-
tive sedation are not sufficiently understood and there-
fore it has been concluded that “there is no scale
available to assess the patient’s comfort during sedation”.
These findings cause an even bigger concern considering
the evidence that family members of patients, compared
with caregivers, often have different perceptions of a pa-
tient’s comfort and their quality of dying during CDS.
While family members tend to overestimate pain, care-
givers often seem to rather underestimate it [11]. Fur-
thermore, interrater reliability among nurses and
physicians often seems poor [12].
Problems with (un)awareness
In recent years, doubts have risen on whether patients la-
beled ‘unconscious’ really are completely insensate and
unaware. Studies in different types of patients and settings
that critically reviewed awareness, consistently reported
that persons were, in contrast to what was assumed by the
caregivers, not always (completely) unaware. For example,
several studies have shown that patients diagnosed with a
vegetative state (currently also called ‘unresponsive wake-
fulness syndrome’) did show some (minimal) clinical signs
of conscious awareness in about 40% of the cases [13]. In
some cases, a purportedly unconscious patient could even
reliably generate appropriate EEG responses to two dis-
tinct commands and occasionally was even able to estab-
lish basic communication with ‘yes’ or ‘no’ answers using
functional Magnetic Resonance Imaging (fMRI) [14].
These findings demonstrate that at least a minority of
clinically diagnosed unresponsive patients shows some re-
sidual cognitive function and conscious awareness and
that even skilled caregivers were not able to recognize
[13]. Also, patients with locked-in syndrome may be
mistakenly considered unconscious as may some (rare)
patients during general anesthesia [15]. In contrast to the
setting where surgical or intensive care patients are man-
aged, advanced monitoring equipment is usually lacking
in palliative or home care settings. Terminal or palliative
sedated patients ultimately die and therefore patient self-
reporting is missing.
The above findings show that the ‘traditional’ clinical
tools and procedures to assess comfort and awareness in
dying non-communicative patients have important meth-
odological limitations. It should be noted that the prob-
lems with assessments are not to be ascribed to a lack of
competence in the caregivers, but are of a much more
fundamental nature: the absence of reliable tools. The de-
velopers of guidelines are aware of these limitations. Al-
though guidelines refer to some scales, the recent Belgian
guideline rightly stresses that “their utility in palliative care
is not proven” [16]. The current guidelines for CDS are
limited to suggest “a daily visit of the physician” and to
“continue attention for possible expressions of discomfort
(e.g. facial expressions, movements…)” [3, 16].
Problems with the titration of drugs
Since the aim of CDS is to give optimal comfort, but not
to hasten death, the principle of ‘proportionality’ is a
pivotal aspect of this treatment and hence the guidelines
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state that sedation should be ‘no deeper than necessary
to avoid suffering’ [1, 16]. To meet this principle of pro-
portionality, caregivers administer the doses of the drugs
so that they are high enough to provide comfort but
should not hasten death. Studies have shown that CDS
does not usually affect survival time [17]. However, as
palliative sedation is considered ‘slow euthanasia’ by
some, physicians may be ‘extra careful’ with the use of
high doses of sedative medication. Several studies have
reported underuse of medicines due to a lack of know-
ledge, unwarranted beliefs, to avoid the perception of
giving ‘excessive’ doses and even because of fear among
caregivers of being accused of ‘killing’ the patient [18].
How to improve assessments of suffering?
Although measuring pain and awareness in non-
communicative dying patients is challenging, it is pos-
sible. In recent years functional neuroimaging, like func-
tional Magnetic Resonance Imaging (fMRI) and
electroencephalography (EEG), have shown to be prom-
ising technologies to detect pain that otherwise cannot
be observed or detected with the ‘traditional’ methods
[14]. Although these technologies have the potential to
provide objective quantifiable indicators for distress and
awareness in non-communicative patients and to differ-
entiate several types of discomfort (e.g., pain versus de-
lirium), they have strikingly not yet been used to
establish reliability of the current assessments for non-
communicative patients. It is remarkable that, given the
increasing incidence of CDS, there is so little concern
about the possibility that patients may experience an un-
comfortable dying phase while being unable to signal
their suffering. An assessment tool that would allow cli-
nicians to more accurately determine the appropriate
doses of medications would encourage more vigorous
symptom management in the dying.
Paradoxically, the inability to report distress might also
be aggravated or become complete by the use of drugs
that might abolish potential further communication and
even facial expressions [19]. Hence, some patients might
have subjective phenomenological awareness or suffering
with very limited, fluctuating or absent behavioral motor
signs of distress [20]. The fact that neuroimaging or
electrophysiology recordings have not been used so far
to validate the assessment tools for distress in non-
communicative patients, even when doubts about these
tools have arisen, may be related to the reluctance in
palliative and end-of-life care to embarrass patients with
high-tech equipments as in most cases, patients have
already experienced a long treatment period.
In our view, we therefore urgently need a triangulation
of methods by which existing scales, qualitative methods
and neuroimaging are combined. Each method has its
potential and limitations but combined they can be used
to validate the commonly used observational scales. The
COMPAS (COMfort in PAlliative Sedation) study proto-
col seeks to address this. As part of the grant application
process by the Research Foundation - Flanders (FWO),
the study design has been scientifically peer reviewed.
Aims of the study
 To better understand how unconscious palliative
sedated patients experience the last days of their life.
 To find out if they are really free of pain.
 To evaluate to what degree assessments of comfort
based on behavioral observations are in line with the
results from a brain function monitor and a ANI-
monitor (analgesia nociception index).
 Additionally we want to find out if changes in the
measured depth of sedation can be experienced by
the patient, caregivers and relatives, especially in the
last moments of life when sometimes unexpected
changes have been measured.
Research questions
1. Are sedated non-communicative dying patients free
of pain and other kinds of discomfort?
2. Do the findings of the different assessment methods
correspond to each other? In casu:
a. The commonly used assessments (observational
scales)
b. The perceptions of family members
c. The neurophysiological measurements
3. Are there differences according to the setting? In
casu:
a. Homes for the elderly
b. Hospitals (with Palliative Care Units (PCU) and/
or Intensive Care Units (ICU))
4. What is the effect of contextual factors:
a. Medical and pharmacological factors (diseases,
medical condition, feeding, medication, etc.).
b. Environmental factors (e.g. the presence of next
of kin, noises etc.)
If one or more observational scales provide conclusive
results that correspond to the results of the EEG and/or
ANI measurement, this can be considered validation. In
that case it would seem that observational scales can be
reliably used in the palliative population. If not, then we
may need to rethink our ways of measuring comfort in
dying patients.
Methods/design
Because of the complexity of the problem (discomfort is
the result of many factors that, for ethical and practical
reasons, researchers cannot control) and the explorative
nature of this study, it would be conceived as a multi-
case study in which the setting and participants are
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deliberately chosen. The aim is not to achieve represen-
tativity, but rather to describe some typical cases which
can provide maximum insight.
Participants
In modal hospitals and modal homes for the elderly, forty
patients will be selected. In each setting 20 participants
will be included consecutively, which should result in 40
detailed case studies. Patients will be deliberately selected
to gain maximum insight and reflect variability regarding
medical conditions.
Inclusion criteria
Patients may be included if they are considered by their
treating physician as:
1. in their last week of life
2. in conditions that might, when not treated, cause
high levels of distress
3. palliative sedation will be started
The treating physicians (specialists at the PCU/ICU or
general practitioners at homes for the elderly) will be
asked to determine whether or not the patients meet
these conditions by means of a checklist on these 4 cri-
teria. To optimally reflect daily practice, no further spe-
cific instructions will be given on how to evaluate these
criteria and treatment will be according to the physi-
cian’s judgment and the best practice.
Procedures
For this prospective study methods from social sciences
(qualitative data collection based on interviews, observation)
, quantitative assessments (scales to assess awareness and
discomfort) and neurophysiological data will be combined.
Hence, a combination of methods that can be considered
fairly objective (e.g. EEG and physiological parameters) and
rather subjective methods (e.g. observations by family mem-
bers) will be used to assess discomfort and awareness.
Therefore, the following data will be collected:
1. Assessment by caregivers (physicians and nurses) in
the routine manner. As explained above, this can be based
either on their ‘experience’ or on tools they routinely use
in their practice. Every day all treating physicians and
nurses will be asked to fill in a brief questionnaire (3 VAS
scales) on the patient’s level of awareness (no awareness-
completely aware), comfort (no pain – very severe pain)
and ability to communicate (no communication possible -
full communication possible). After the patient has de-
ceased, all caregivers will be interviewed and asked to
comment on their assessments.
2. Family members’ perception of the quality of the dying
process, their opinion about the patient’s comfort and aware-
ness and their impression of whether they had any kind of
(non-verbal) contact with the patient. Parallel with the above
described procedure, family members will also be asked to
fill in the same 3 VAS scales. Semi-structured interviews will
be conducted before and after the patient has deceased.
3. Assessment by 2 trained investigators using 1 scale
that is mentioned in the Flemish palliative sedation
guideline and 3 other scales that have been proposed in
the literature [16]:
3.1 CCPOT (Critical Care Pain Observational Tool), a
tool specifically developed for use in patients with
limited consciousness [8].
3.2 RASS (Richmond Agitation-Sedation Scale) [21].
3.3 M-ESAS (Modified Edmonton Symptom
Assessment Scale, validated for a Flemish Palliative
Care Population) [22].
3.4 BPS-NI (Behavioral Pain Scale Non-Intubated) [23].
4. Neurophysiological assessments of distress and level
of awareness using fMRI has been successfully used to
detect awareness and distress that could not be detected
by thorough behavioral assessment [10, 13, 14, 24, 25].
Issues of availability and extra stress incurred by patients
when transferred are making the use of fMRI for prac-
tical and ethical reasons not feasible.
EEG has recently been shown to provide a feasible and
methodologically sound alternative for bedside detection
of awareness and pain [26–28]. Although results from
these methods need to be interpreted with caution, they
can provide important indicators that are especially valu-
able for assessments in non-communicative patients.
Data will be collected with a Neurosense monitor that
can easily be used and set up. It displays two frontal
EEG signals, and calculates a number of parameters in-
cluding the bilateral WAVcns index (Wavelet Anesthetic
Value for Central Nervous System), ranging from 100
(awake) to 0 (flat EEG). The lower the index, the lower
the likelihood of consciousness. The recommended
WAVcns for general anesthesia with low probability of
consciousness is between 60 and 40. For technical details
on the respective measurements of awareness and distress
we refer to Schulz E et al. and Cruse D et al. [24, 29].
Additionally, heart rate variability (HRV) will be mea-
sured using an ANI monitor. HRV is the variation in
time intervals between heartbeats and reflects the effect
of the vagus nerve on the heart, which is inhibited dur-
ing pain. It has already been widely studied in relation-
ship to pain, and seems to be a promising biomarker
[30]. However, studies with palliative sedated patients
show contradicting results thus far [31, 32]. A promising
non-invasive technique is the continuous monitoring of
HRV transformed into an analgesia nociception index
(ANI, 0–100), which assesses parasympathetic activity as a
possible measure of nociception [33]. The ANI provides
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greater stability than raw indices of HRV. A recent study
showed that ANI is effective in detecting pain in deeply
sedated critically ill patients [34]. The analgesia nociception
index is a non-invasive tool based on the analysis of the re-
spiratory fluctuations of heart rate that mainly reflect the
variability in the parasympathetic tone. The NeuroSense
and ANI monitor record the EEG and ECG signal continu-
ously, enabling a quantitative assessment of these parame-
ters. The data can be used to assess the level of sedation
but also to register negative and positive emotion-related
activities such as the voice of loved ones and distress.
5. Observation of the patient to detect e.g. restlessness,
movements etc. To assure a more precise and reliable
observation, video and audio registrations will be made
of the patient.
6. Background information based on the patient’s med-
ical file, observation and interviews.
6.1 Characteristics of the patient (age, gender, profession…).
6.2 Medical information: history, medical condition,
feeding, medication, etc.).
6.3 Pharmacological information (especially medication
aimed to improve comfort e.g. sedatives, painkillers etc.)
6.4 Environmental information (e.g. the presence of
next of kin, noises etc.)
Data will be collected every day, starting from the day
when palliative sedation is initiated until the patient dies.
Neurophysiological data will be collected continuously.
Video and audio registrations will preferably take place
non-stop (in consultation with the family) but may be
interrupted during family visits to respect privacy.
Sample size
A previous study learns that a correlation of 0.45 was found
between Bispectral Index (BIS) monitoring and the Ramsay
scale [35]. A similar correlation can be expected between
the WAVcns and the VAS in the present study. However, in
order to become a successful measure of sedation, we re-
quire the correlation between both measures to be signifi-
cantly higher than 0.30. Although EEG monitoring would
allow continuous data collection, the VAS will be com-
pleted only once or twice a day by relatives (more often by
trained investigators) to keep burden as low as possible. As
we expect patients can be monitored during 2–3 days on
average, some 5 VAS scores (from relatives, more from
staff) will be available per patient. This results in a close to
80% probability for our study to find a correlation higher
than 0.30 if the actual correlation is 0.45.
Data-analysis
Analysis of qualitative data (interviews and video) will be
done in accordance with the interpretative paradigm,
aiming to understand meanings and actions and how
people construct them, and follow the principles of
Grounded Theory [36]. Coding of the neurological data
will be performed by an experienced neurologist.
Video registrations will be coded in events and ana-
lysed using nVivo, a tool for qualitative analysis that en-
ables researchers to code and analyze events and also
allows importing and correlating video and neurophysio-
logical data. A coding scheme will be developed to code
behavioral signs of the patient, treatments (painful acts,
medical acts, etc.) and environmental circumstances and
changes (visits, noises…).
The involved researchers will intensively cooperate in
the interpretation of the data. All data will be used for
an overall assessment (using the transdisciplinary mixed
methods case study approach) [37]. The analysis will
focus on:
– comparison of the results based on the different
methods
– detection of changes in level of comfort and
awareness
The findings and interpretations will then be discussed
in a multidisciplinary team consisting of members of the
Mental Health and Wellbeing Research Group, the de-
partment of Anesthesiology and Perioperative Medicine,
the department of Experimental Psychology (all from the
Vrije Universiteit Brussel) and the Coma Science Group
(University of Liège).
Ethical aspects
Video/audio registration will only be made after explicit
consent of the patient (if possible) and his next-of-kin.
The study protocol is approved by the biomedical ethics
committee of the VUB/UZ Brussel (BUN 14320136504)
and additional approval will be asked from participating
hospitals. Written informed consent will be asked from
the patient or his/her substitute decision maker.
We are aware that the data collection is challenging
and delicate, especially because we will deal with dying
patients and their family. Therefore, special attention
will be given to clear communication about the aims of
our study. We will explain participants that the study is
not invasive and will not hinder the (sedated) patient
and that the aim is to minimize the risk for suffering.
Discussion
The objectives of the COMPAS study are to determine if
more objective measures based on EEG and HRV are
potentially useful in the assessment of comfort and pain
during palliative sedation. To achieve these goals a
transdisciplinary mixed methods multiple case study de-
sign is adopted, where both quantitative and qualitative
data are being linked to neurophysiological data
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collected by monitoring devices. The methodological
background of this particular type of mixed methods re-
search has been described by Deschepper et al. in the
paper Linking numbers to perceptions and experiences:
why we need transdisciplinary mixed-methods combining
neurophysiological and qualitative data [37]. Next to the
already mentioned idiosyncratic aims the present study
also aspires to be the first worked example of this meth-
odological approach.
Strengths
To our knowledge this is one of the very few studies
which seek to take an in-depth view on the assessment of
pain and discomfort in non-communicative palliative se-
dated patients. To this effect multiple ways of data collec-
tion are used, in particular both objective and subjective
assessments, with the intent to develop as complete a pic-
ture as possible of the subject at hand. By using a transdis-
ciplinary approach throughout the entirety of the study, a
high degree of integration is achieved; researchers from
different disciplines were involved in all aspects of the
study, as were members of the palliative community, pa-
tients and family members to decide what is ethically and
practically acceptable.
Limitations
There are a number of limitations to this study, partly be-
cause doing research at the end of life is delicate, and
partly because of the methodological challenges in dealing
with non-communicative unconscious patients. It is likely
that more extensive measures of brain activity such as
fMRI would yield more sophisticated data, but, more ex-
tensive neurophysiological monitoring would be more in-
vasive as compared to a NeuroSense monitor and this
would likely be more disturbing for family members.
From a methodological point of view, the greatest
challenge will be how to combine the different types of
data (neurophysiological, quantitative and qualitative) to
assess a phenomenon which is considered to be best
assessed by self-reporting. Since the latter is not an op-
tion, the best possible way to approximate objectivity is
by triangulation, combining different measures that are
collected at the same moment and analyzed transver-
sally. However gathering different types of data (e.g. as-
sessments of family members) may prove difficult in
such a sensitive setting.
Opportunities
Completion of this project will result in a deeper under-
standing of how the assessment of (dis)comfort and pain
during palliative sedation may be potentially improved
by including more objective neurophysiological parame-
ters. Additionally, our findings will clarify if the present
practices associated with assessing patient comfort
during palliative sedation (based on observational scales)
need to be reconsidered. The transdisciplinary approach
of the researchers involved in the COMPAS study fur-
ther ensures a maximum level of ecological validity
when studying such complex phenomenon.
Threats
The threats to the successful conduct of this study relate
mainly to the reluctance of the patient or his substitute de-
cision maker to be bothered with participating in a study at
such a sensitive and difficult moment. After all, one of the
ideas behind the palliative care concept is to give comfort
to the patient and that includes an environment that feels
more natural and home-like, so the concept of using moni-
toring devices in such a setting seems contra-indicated.
This concern has been voiced by palliative caregivers. How-
ever, we feel confident that with proper and sensible ex-
planation the importance of this study can be made
understood. Furthermore every aspect of the study has
been designed to be as minimally burdensome as possible.
Already a pilot case has demonstrated the feasibility of this
design for all actors involved, the protocol for this observa-
tional study has been registered retrospectively at Clinical-
Trials.gov (ID NCT03273244) [38].
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